Zentalis Pharmaceuticals (ZNTL) Deferred Taxes (2022 - 2023)
Zentalis Pharmaceuticals' (ZNTL) quarterly Deferred Taxes came in at -$756000.0 in Q2 2023, down 1121.62% year-on-year from $74000.0 in Q2 2022, and down 679.38% quarter-over-quarter from -$97000.0 in Q1 2023.
Zentalis Pharmaceuticals (ZNTL) Deferred Taxes (2022 - 2023) Analysis & Trends
Zentalis Pharmaceuticals' Deferred Taxes history runs 2 years deep, the most recent figure standing at -$756000.0 for Q2 2023.
- On a quarterly basis, Deferred Taxes fell 1121.62% year-over-year to -$756000.0 in Q2 2023; TTM through Mar 2024 was -$756000.0, a 4.55% increase from a year earlier, with the FY2023 full-year figure at -$853000.0, down 10.92% from the prior year.
- Deferred Taxes fell to -$756000.0 in Q2 2023 per ZNTL's latest filing, from -$97000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $74000.0 in Q2 2022 and bottomed at -$769000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zentalis Pharmaceuticals | 312.67 Mn | 312.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -756,000.00 |
| Mar 31, 2023 | -97,000.00 |
| Dec 31, 2022 | -769,000.00 |
| Jun 30, 2022 | 74,000.00 |
| Mar 31, 2022 | -74,000.00 |